- Home
- KNSA vs SKT Comparison
KNSA vs SKT Comparison
Compare KNSA & SKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KNSA | SKT |
|---|---|---|
| Founded | 2015 | 1981 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.7B |
| IPO Year | 2018 | 1994 |
Fundamental Metrics
Financial Performance| Metric | KNSA | SKT |
|---|---|---|
| Price | $77.47 | $38.92 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 6 |
| Target Price | ★ $60.86 | $37.17 |
| AVG Volume (30 Days) | 686.4K | ★ 841.0K |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 3.18% |
| EPS Growth | ★ 225.00 | N/A |
| EPS | 0.27 | ★ 0.53 |
| Revenue | ★ $677,564,000.00 | N/A |
| Revenue This Year | $37.48 | $0.37 |
| Revenue Next Year | $17.87 | $3.90 |
| P/E Ratio | $285.48 | ★ $72.85 |
| Revenue Growth | ★ 60.09 | N/A |
| 52 Week Low | $32.69 | $31.13 |
| 52 Week High | $82.94 | $42.53 |
Technical Indicators
Market Signals| Indicator | KNSA | SKT |
|---|---|---|
| Relative Strength Index (RSI) | 65.81 | 37.42 |
| Support Level | $40.06 | $38.75 |
| Resistance Level | $82.94 | $41.53 |
| Average True Range (ATR) | 3.75 | 0.90 |
| MACD | 0.20 | -0.40 |
| Stochastic Oscillator | 76.67 | 12.46 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About SKT Tanger Inc.
Tanger Inc is an owner and operator of outlet and open-air centers in the United States and Canada. It is a fully-integrated, self-administered and self-managed REIT, which focuses on developing, acquiring, owning, operating and managing outlet and open-air shopping centers. Its consolidated portfolio consisted of 31 outlet centers and 2 open-air lifestyle centers.